Crystal structures of the p21-activated kinases PAK4, PAK5, and PAK6 reveal catalytic domain plasticity of active group IIPAKs

被引:96
作者
Eswaran, Jeyanthy [1 ]
Lee, Wen Hwa
Debreczeni, Judit E.
Filippakopoulos, Panagis
Turnbull, Andrew
Fedorov, Oleg
Deacon, Sean W.
Peterson, Jeffrey R.
Knapp, Stefan
机构
[1] Univ Oxford, Struct Genom Consortium, Botnar Res CTr, Oxford OX3 7LD, England
[2] Fox Chase Canc Ctr, Tumor Cell Biol, Philadelphia, PA 19111 USA
基金
英国惠康基金;
关键词
D O I
10.1016/j.str.2007.01.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p21-activated kinases have been classified into two groups based on their domain architecture. Group II PAKs (PAK4-6) regulate a wide variety of cellular functions, and PAK deregulation has been linked to tumor development. Structural comparison of five high-resolution structures comprising all active, monophosphorylated group II catalytic domains revealed a surprising degree of domain plasticity, including a number of catalytically productive and nonproductive conformers. Rearrangements of helix alpha C, a key regulatory element of kinase function, resulted in an additional helical turn at the alpha C N terminus and a distortion of its C terminus, a movement hitherto unseen in protein kinases. The observed structural changes led to the formation of interactions between conserved residues that structurally link the glycine-rich loop, aC, and the activation segment and firmly anchor aC in an active conformation. Inhibitor screening identified six potent PAK inhibitors from which a tri-substituted purine inhibitor was cocrystallized with PAK4 and PAK5.
引用
收藏
页码:201 / 213
页数:13
相关论文
共 63 条
[1]   PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia [J].
Abo, A ;
Qu, J ;
Cammarano, MS ;
Dan, CT ;
Fritsch, A ;
Baud, V ;
Belisle, B ;
Minden, A .
EMBO JOURNAL, 1998, 17 (22) :6527-6540
[2]   Activation loop phosphorylation and catalysis in protein kinases: Is there functional evidence for the autoinhibitor model? [J].
Adams, JA .
BIOCHEMISTRY, 2003, 42 (03) :601-607
[3]   Serine-53 at the tip of the glycine-rich loop of cAMP-dependent protein kinase: Role in catalysis, P-site specificity, and interaction with inhibitors [J].
Aimes, RT ;
Hemmer, W ;
Taylor, SS .
BIOCHEMISTRY, 2000, 39 (28) :8325-8332
[4]   Cdc2-cyclin E complexes regulate the G1/S phase transition [J].
Aleem, E ;
Kiyokawa, H ;
Kaldis, P .
NATURE CELL BIOLOGY, 2005, 7 (08) :831-U93
[5]   Biology of the p21-activated kinases [J].
Bokoch, GM .
ANNUAL REVIEW OF BIOCHEMISTRY, 2003, 72 :743-781
[6]   Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in Moloney murine leukemia virus (PIM-1) kinase [J].
Bullock, AN ;
Debreczeni, JÉ ;
Fedorov, OY ;
Nelson, A ;
Marsden, BD ;
Knapp, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (24) :7604-7614
[7]   Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines [J].
Callow, MG ;
Clairvoyant, F ;
Zhu, S ;
Schryver, B ;
Whyte, DB ;
Bischoff, JR ;
Jallal, B ;
Smeal, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (01) :550-558
[8]   Activation mechanism of the MAP kinase ERK2 by dual phosphorylation [J].
Canagarajah, BJ ;
Khokhlatchev, A ;
Cobb, MH ;
Goldsmith, EJ .
CELL, 1997, 90 (05) :859-869
[9]   Identification of an autoinhibitory domain of p21-activated protein kinase 5 [J].
Ching, YP ;
Leong, VYL ;
Wong, CM ;
Kung, HF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (36) :33621-33624
[10]   Nucleocytoplasmic shuttling of Pak5 regulates its antiapoptotic properties [J].
Cotteret, S ;
Chernoff, J .
MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (08) :3215-3230